Both in Pharmaceuticals
Rhythm Pharmaceuticals vs Amneal Pharmaceuticals
Over the past year RYTM returned −19.2% and AMRX returned +93.2%; their daily moves had a correlation of 0.33.
RYTM −19.2% AMRX +93.2%Growth of $1, one year, split-adjusted
| Metric | RYTM | AMRX |
|---|---|---|
| Price | $89.27 | $20.38 |
| Market cap | $6.15B | $7.10B |
| Today | −1.79% | −0.49% |
| 1 month | −9.2% | +2.9% |
| 6 months | +4.2% | +62.8% |
| Year to date | −16.6% | +61.7% |
| 1 year | −18.2% | +95.4% |
| Revenue growth (YoY) | +46.9% | +9.9% |
| Gross margin | 87.5% | 42.0% |
| Net margin | −70.7% | 7.2% |
| P/E (TTM) | — | 45.1× |
| Price / sales | 25.6× | 2.3× |
| Net cash | $224.8M | -$2.54B |
| Dividend yield | — | — |
| Volatility (60d) | 36.2% | 37.8% |
| Short % of float | 16.7% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).